RT @ISRCTN: A randomised phase III trial to evaluate the Duration of ANti-PD1 monoclonal antibody Treatment in patients with metastatic mEl…
21,508 followers
4,252 followers
A randomised phase III trial to evaluate the Duration of ANti-PD1 monoclonal antibody Treatment in patients with metastatic mElanoma The DANTE study protocol registered at #ISRCTN has been published in #BMCCancer @BMC_series https://t.co/7eJrZ36ZbT
54 followers
RT @sdanson1: Protocol paper for the NIHR funded DANTE study looking at duration (one year vs two years/longer) of immunotherapy in melanom…
1,101 followers
Protocol paper for the NIHR funded DANTE study looking at duration (one year vs two years/longer) of immunotherapy in melanoma is published. Patient/clinical/methodological collaboration. Thanks all @suebell71 @c_ottensmeier @plummer_ruth @focusonmelanoma